The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Levothyroxine or minimally invasive therapies for benign thyroid nodules
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2014
|
DOI | 10.1002/14651858.cd004098.pub2 |
Pubmed ID | |
Authors |
Elizabeth Bandeira‐Echtler, Karla Bergerhoff, Bernd Richter |
Abstract |
Thyroid nodules (TN) are common in the adult population. Some physicians use suppressive levothyroxine (LT4) therapy to achieve a reduction in the number and volume of TN. In addition, minimally invasive treatments, such as percutaneous ethanol injection (PEI) sclerotherapy, laser photocoagulation (LP), and microwave (MW), radiofrequency (RF) and high-intensity focused ultrasound (HIFU) ablation, have been proposed, especially for pressure symptoms and cosmetic complaints, as an alternative to surgery. However, the risk to benefit ratio of all treatments for benign TN is currently unknown. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Nigeria | 1 | 10% |
Spain | 1 | 10% |
Unknown | 8 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 70% |
Practitioners (doctors, other healthcare professionals) | 3 | 30% |
Mendeley readers
The data shown below were compiled from readership statistics for 396 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | <1% |
United States | 1 | <1% |
Portugal | 1 | <1% |
Ireland | 1 | <1% |
Unknown | 391 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 54 | 14% |
Student > Bachelor | 44 | 11% |
Researcher | 42 | 11% |
Student > Ph. D. Student | 32 | 8% |
Student > Postgraduate | 26 | 7% |
Other | 85 | 21% |
Unknown | 113 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 135 | 34% |
Nursing and Health Professions | 40 | 10% |
Psychology | 17 | 4% |
Biochemistry, Genetics and Molecular Biology | 11 | 3% |
Unspecified | 11 | 3% |
Other | 54 | 14% |
Unknown | 128 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2019.
All research outputs
#4,522,026
of 26,557,909 outputs
Outputs from Cochrane database of systematic reviews
#6,826
of 13,245 outputs
Outputs of similar age
#40,661
of 243,962 outputs
Outputs of similar age from Cochrane database of systematic reviews
#120
of 236 outputs
Altmetric has tracked 26,557,909 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,245 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.7. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,962 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.